Literature DB >> 24682981

Clinical retrospective analysis of cases with multiple primary malignant neoplasms.

L L Xu1, K S Gu2.   

Abstract

The etiological factors, clinical characteristics, diagnosis, treatment strategies, and prognosis of multiple primary malignant neoplasms (MPMNs) were investigated in order to improve its diagnosis and therapy. Clinical data of 170 patients with MPMN who were admitted to the Oncology Department of the First Affiliated Hospital of Anhui Medical University from January 2004 to April 2010 were collected and analyzed retrospectively. The overall incidence of MPMNs was 2.25%. There were 167 cases with duplex primary cancers, 2 cases with triple primary cancers, 1 case with quadruple primary cancer, 46 synchronous MPMNs (SMPMNs), and 124 metachronous MPMNs (MMPMNs). There were 344 malignant neoplasms in the 170 MPMN patients, of which 161 were in the alimentary system, 48 in the respiratory system, 63 in mammary glands, 30 in the genital system, 7 in the urinary system, 23 in the head and neck, and the other 12 were in the brain, hematological system, and soft tissue. There were 22 cases of bilateral primary breast cancer and 41 cases of digestive MPMN. With a median survival time of 24 months, the 1-, 3-, and 5-year cumulative survival rates in the 170 patients were 68.8, 39.1, and 25.2%, respectively. The most common locations of MPMN were the alimentary system, mammary gland, and respiratory system. MPMN usually occurred in distinct organs of identical systems, conjugate organs, or identical organs. The survival rate of SMPMN was similar to that of MMPMN. There were differences in principles of treatment and diagnosis between MPMN and metastasis or recurrent cancers.

Entities:  

Mesh:

Year:  2014        PMID: 24682981     DOI: 10.4238/2014.March.12.19

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  21 in total

Review 1.  Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.

Authors:  Alessandro De Luca; Federico Frusone; Massimo Vergine; Rosario Cocchiara; Giuseppe La Torre; Laura Ballesio; Massimo Monti; Maria Ida Amabile
Journal:  In Vivo       Date:  2019 Jul-Aug       Impact factor: 2.155

Review 2.  Synchronous quintuple primary gastrointestinal tract malignancies: Case report.

Authors:  Soo-Hong Kim; Byung-Soo Park; Hyun Sung Kim; Jae Hun Kim
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

3.  Germline genetic variants in men with prostate cancer and one or more additional cancers.

Authors:  Patrick G Pilié; Anna M Johnson; Kristen L Hanson; Megan E Dayno; Ashley L Kapron; Elena M Stoffel; Kathleen A Cooney
Journal:  Cancer       Date:  2017-06-28       Impact factor: 6.860

4.  Triple synchronous primary malignancies: a rare occurrence.

Authors:  Heather Katz; Hassaan Jafri; Linda Brown; Toni Pacioles
Journal:  BMJ Case Rep       Date:  2017-06-05

5.  A rare case of synchronous multiple primary malignancies of breast cancer and diffuse large B-cell lymphoma that responded to multidisciplinary treatment: a case report.

Authors:  Yuichi Ueda; Yuko Makino; Taro Tochigi; Yoshikazu Ota; Hideki Hidaka; Takeshi Nakamura; Kiichiro Beppu; Jiro Ohuchida; Seiichi Odate; Soshi Terasaka; Takahiro Nishida; Masaki Yoshida; Ryuichiro Kimura; Kousuke Marutsuka; Naoki Otomo
Journal:  Surg Case Rep       Date:  2022-05-19

6.  Nine primary malignant neoplasms-involving the esophagus, stomach, colon, rectum, prostate, and external ear canal-without microsatellite instability: a case report.

Authors:  Keiichi Arakawa; Keisuke Hata; Yoko Yamamoto; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Hiroaki Nozawa; Masafumi Yoshida; Hiroshi Fukuhara; Mitsuhiro Fujishiro; Teppei Morikawa; Tatsuya Yamasoba; Kazuhiko Koike; Masashi Fukayama; Toshiaki Watanabe
Journal:  BMC Cancer       Date:  2018-01-04       Impact factor: 4.430

7.  Successful treatment of three synchronous primary malignant tumours-reflection on surgical, pathological and oncological aspects and decision making.

Authors:  Emese Irma Ágoston; Áron Somorácz; Lilla Madaras; Attila Zaránd; Gyöngyvér Szentmártoni; Zsuzsanna Orosz; Magdolna Dank; Zsolt Baranyai
Journal:  J Surg Case Rep       Date:  2018-04-06

8.  Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer.

Authors:  Masahiro Yamasaki; Naomi Saito; Yu Hada; Sayaka Miyamoto; Hideharu Okanobu; Naoya Ikeda; Wakako Daido; Sayaka Ishiyama; Naoko Deguchi; Masaya Taniwaki; Nobuyuki Ohashi
Journal:  Case Rep Oncol       Date:  2017-04-24

9.  Multiple primary synchronous malignant tumors.

Authors:  Alberto Testori; Ugo Cioffi; Matilde De Simone; Francesco Bini; Adriano Vaghi; Alessandro A Lemos; Michele M Ciulla; Marco Alloisio
Journal:  BMC Res Notes       Date:  2015-11-27

10.  Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up.

Authors:  Wei Xu; Wenjun Liao; Penglei Ge; Jinjun Ren; Haifeng Xu; Huayu Yang; Xinting Sang; Xin Lu; Yilei Mao
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.